ADARx Pharmaceuticals (ADRX) Revenue & Revenue Breakdown
ADARx Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$3.45M
Latest Revenue (Q)
$2.22M
ADARx Pharmaceuticals Revenue by Period
ADARx Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $3.45M | - |
ADARx Pharmaceuticals generated $3.45M in revenue during NA 2025, up 0.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
ADARx Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-09-30 | $2.22M | 197.18% |
| 2026-06-30 | $746.00K | -65.14% |
| 2026-03-31 | $2.14M | 32.06% |
| 2025-12-31 | $1.62M | - |
ADARx Pharmaceuticals generated $2.22M in revenue during Q3 2026, up 197.18% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
ADARx Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| STOK | Stoke Therapeutics | $184.42M | $11.26M |
| ARCT | Arcturus Therapeutics | $82.03M | $18.30M |
| WVE | Wave Life Sciences | $42.73M | $13.16M |
| MGTX | MeiraGTx | $33.28M | $4.81M |
| RNA | Atrium Therapeutics | $18.75M | $15.32M |
| PRQR | ProQR Therapeutics | $6.38M | $4.48M |
| PRME | Prime Medicine | $4.63M | $4.21M |
| ADRX | ADARx Pharmaceuticals | $3.45M | $2.22M |
| SLN | Silence Therapeutics | $559.00K | - |
| RNAZ | TransCode Therapeutics | - | - |
| BNTC | Benitec Biopharma | - | - |